HIGHLIGHTS
- What: The authors report six patients treated preoperatively with TKIs. This study had several limitations, including the absence of histopathological diagnosis through biopsy in all cases. This study demonstrated favorable treatment outcomes, including tumor shrinkage, achieved through the safe use of molecular-targeted drugs prior to PCA.
- Who: Preoperative Tyrosine Kinase Inhibitors et al. from the Department of Urology, The Jikei University School of Medicine, Kashiwa Hospital, Chiba, JPN Department of have published the research work: Received 04/30/2024 Review began 05/03/2024 Review ended 05/12/2024 Published 05/15/2024, in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.